Your browser doesn't support javascript.
loading
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Fujitani, Kazumasa; Shitara, Kohei; Takashima, Atsuo; Koeda, Keisuke; Hara, Hiroki; Nakayama, Norisuke; Hironaka, Shuichi; Nishikawa, Kazuhiro; Kimura, Yutaka; Amagai, Kenji; Hosaka, Hisashi; Komatsu, Yoshito; Shimada, Ken; Kawabata, Ryohei; Ohdan, Hideki; Kodera, Yasuhiro; Nakamura, Masato; Nakajima, Takako Eguchi; Miyata, Yoshinori; Moriwaki, Toshikazu; Kusumoto, Tetsuya; Nishikawa, Kazuo; Ogata, Kazuhiro; Shimura, Masashi; Morita, Satoshi; Koizumi, Wasaburo.
Afiliação
  • Fujitani K; Department of Surgery, Osaka General Medical Center, 3-1-56, Bandaihigashi, Sumiyoshi-ku, Osaka, 558-0056, Japan. fujitani@gh.opho.jp.
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Takashima A; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Koeda K; Department of Medical Safety Science, Iwate Medical University, Morioka, Japan.
  • Hara H; Department of Gastroenterology, Saitama Cancer Center, Ina-machi, Japan.
  • Nakayama N; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
  • Hironaka S; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Nishikawa K; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan.
  • Kimura Y; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Amagai K; Department of Surgery, Sakai City Medical Center, Sakai, Japan.
  • Hosaka H; Department of Gastroenterology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
  • Komatsu Y; Division of Gastroenterology, Gunma Prefectural Cancer Center, Ohta, Japan.
  • Shimada K; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Kawabata R; Division of Medical Oncology, Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan.
  • Ohdan H; Department of Surgery, Osaka Rosai Hospital, Osaka, Japan.
  • Kodera Y; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Nakamura M; Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nakajima TE; Aizawa Comprehensive Cancer Center, Aizawa Hospital, Nagano, Japan.
  • Miyata Y; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Moriwaki T; Kyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy, Kyoto University Hospital, Kyoto, Japan.
  • Kusumoto T; Department of Medical Oncology, Saku Central Hospital Advanced Care Center, Saku, Japan.
  • Nishikawa K; Division of Gastroenterology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Ogata K; Department of Gastroenterological Surgery and Clinical Research Institute Cancer Research Division, National Kyushu Medical Center, Fukuoka, Japan.
  • Shimura M; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan.
  • Morita S; Medical Affairs Department, Taiho Pharmaceutical Co., Ltd, Tokyo, Japan.
  • Koizumi W; Data Science Department, Taiho Pharmaceutical Co., Ltd, Tokyo, Japan.
Gastric Cancer ; 24(2): 477-478, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33300101

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article